These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34652264)

  • 1. Direct bisulphite conversion of cervical samples for DNA methylation analysis.
    Verhoef L; Floore AN; Doorn S; Cuschieri K; Bhatia R; Hesselink AT; Meijer CJLM; Steenbergen RDM; Heideman DAM
    Epigenetics; 2022 Oct; 17(10):1173-1179. PubMed ID: 34652264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study.
    Bonde J; Floore A; Ejegod D; Vink FJ; Hesselink A; van de Ven PM; Valenčak AO; Pedersen H; Doorn S; Quint WG; Petry KU; Poljak M; Stanczuk G; Cuschieri K; de Sanjosé S; Bleeker M; Berkhof J; Meijer CJLM; Heideman DAM
    Int J Cancer; 2021 Jan; 148(2):396-405. PubMed ID: 32997803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort.
    Vink FJ; Lissenberg-Witte BI; Meijer CJLM; Berkhof J; van Kemenade FJ; Siebers AG; Steenbergen RDM; Bleeker MCG; Heideman DAM
    Clin Microbiol Infect; 2021 Jan; 27(1):125.e1-125.e6. PubMed ID: 32222459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: Results from an international study.
    Floore A; Hesselink A; Oštrbenk A; Alcaniz E; Rothe B; Pedersen H; Torres Hortal M; Doorn S; Quint W; Petry KU; Poljak M; Cuschieri K; Bonde J; de Sanjosé S; Bleeker M; Heideman D
    J Clin Lab Anal; 2019 May; 33(4):e22854. PubMed ID: 30758084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.
    De Strooper LMA; Berkhof J; Steenbergen RDM; Lissenberg-Witte BI; Snijders PJF; Meijer CJLM; Heideman DAM
    Int J Cancer; 2018 Sep; 143(6):1541-1548. PubMed ID: 29663363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study.
    Vink FJ; Meijer CJLM; Clifford GM; Poljak M; Oštrbenk A; Petry KU; Rothe B; Bonde J; Pedersen H; de Sanjosé S; Torres M; Del Pino M; Quint WGV; Cuschieri K; Boada EA; van Trommel NE; Lissenberg-Witte BI; Floore AN; Hesselink AT; Steenbergen RDM; Bleeker MCG; Heideman DAM
    Int J Cancer; 2020 Aug; 147(4):1215-1221. PubMed ID: 31390052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis.
    Dick S; Kremer WW; De Strooper LMA; Lissenberg-Witte BI; Steenbergen RDM; Meijer CJLM; Berkhof J; Heideman DAM
    Gynecol Oncol; 2019 Aug; 154(2):368-373. PubMed ID: 31182225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.
    De Strooper LMA; Verhoef VMJ; Berkhof J; Hesselink AT; de Bruin HME; van Kemenade FJ; Bosgraaf RP; Bekkers RLM; Massuger LFAG; Melchers WJG; Steenbergen RDM; Snijders PJF; Meijer CJLM; Heideman DAM
    Gynecol Oncol; 2016 May; 141(2):341-347. PubMed ID: 26921784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping.
    Dick S; Vink FJ; Heideman DAM; Lissenberg-Witte BI; Meijer CJLM; Berkhof J
    Br J Cancer; 2022 Feb; 126(2):259-264. PubMed ID: 34743198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.
    Leeman A; Ebisch RMF; Kasius A; Bosgraaf RP; Jenkins D; van de Sandt MM; de Strooper LMA; Heideman DAM; Snijders PJF; Massuger LFAG; Bekkers RLM; Meijer CJLM; van Kemenade FJ; Quint WGV; Melchers WJG
    Gynecol Oncol; 2018 Nov; 151(2):311-318. PubMed ID: 30219239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of molecular markers for cervical screening of women living with HIV in South Africa.
    Kremer WW; van Zummeren M; Breytenbach E; Richter KL; Steenbergen RDM; Meijer CJLM; Dreyer G
    AIDS; 2019 Nov; 33(13):2035-2042. PubMed ID: 31385866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women.
    Bu Q; Wang S; Ma J; Zhou X; Hu G; Deng H; Sun X; Hong X; Wu H; Zhang L; Luo X
    BMC Cancer; 2018 Nov; 18(1):1182. PubMed ID: 30486875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women.
    Dankai W; Khunamornpong S; Siriaunkgul S; Soongkhaw A; Janpanao A; Utaipat U; Kitkumthorn N; Mutirangura A; Srisomboon J; Lekawanvijit S
    PLoS One; 2019; 14(1):e0210289. PubMed ID: 30608989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
    Luttmer R; De Strooper LM; Berkhof J; Snijders PJ; Dijkstra MG; Uijterwaal MH; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; Van Baal WM; Graziosi PG; Quint WG; Heideman DA; Meijer CJ
    Int J Cancer; 2016 Feb; 138(4):992-1002. PubMed ID: 26317579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of FAM19A4/miR124-2 methylation performance in the management of CIN3 diagnosed pregnant women.
    Hampl M; Hesselink AT; Meijer CJLM; Denecke A; Einhorn I; Reinecke-Luethge A; Geppert CI; Jentschke M; ; Petry KU; Hillemanns P
    Int J Cancer; 2022 Nov; 151(9):1578-1585. PubMed ID: 35666529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation: bisulphite modification and analysis.
    Patterson K; Molloy L; Qu W; Clark S
    J Vis Exp; 2011 Oct; (56):. PubMed ID: 22042230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.
    Leeman A; Jenkins D; Del Pino M; Ordi J; Torné A; Doorbar J; Meijer CJLM; van Kemenade FJ; Quint WGV
    Cancer Med; 2020 Apr; 9(7):2454-2461. PubMed ID: 32022461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
    Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
    J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.
    Luttmer R; De Strooper LM; Dijkstra MG; Berkhof J; Snijders PJ; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; van Baal WM; Graziosi PG; Quint WG; Spruijt JW; van Dijken DK; Heideman DA; Meijer CJ
    Br J Cancer; 2016 Aug; 115(5):579-87. PubMed ID: 27415009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
    Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
    Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.